Ukraine. Registration of drugs
State registration of medicinal drugs
Medicinal products can be used in Ukraine only after their state registration. Medicinal products which are prepared in pharmacies of active and supplementary substances upon doctors’ prescriptions (mainline formulas) and upon order of medico-prophylactic institutions (officinal formulas) are not subject to state registration. The procedure for the state drug registration (re-registration) and (re-)registration fee is approved by the Resolution of the CMU dd. 26.05.2005 #376. The MHC of Ukraine registers and re-registers medicinal products upon results of an expert examination of registration materials (registration file) on such drug and its quality control carried out by the Centre. The fee for the state medicinal product (re-) registration shall be paid to the state budget by the applicant in following amounts:
This procedure shall be applied to active substances (active pharmaceutical ingredients), officinal dugs (except for medical immunobiological drugs) as well as preparations registered upon definition of the MHC of Ukraine as medicinal products, in particular: curative cosmetics, disinfectors and diagnostic agents.
Expert examination of the medicinal product registration file submitted for the state (re-) registration has following stages:
The specialized expert examination of the registration file and results of additional examinations (trials) of the medicinal product is conducted in order to reach a motivated conclusion on the efficacy, safety and quality of the drug.
Medicinal products can be used in Ukraine only after their state registration. Medicinal products which are prepared in pharmacies of active and supplementary substances upon doctors’ prescriptions (mainline formulas) and upon order of medico-prophylactic institutions (officinal formulas) are not subject to state registration. The procedure for the state drug registration (re-registration) and (re-)registration fee is approved by the Resolution of the CMU dd. 26.05.2005 #376. The MHC of Ukraine registers and re-registers medicinal products upon results of an expert examination of registration materials (registration file) on such drug and its quality control carried out by the Centre. The fee for the state medicinal product (re-) registration shall be paid to the state budget by the applicant in following amounts:
- For the state (re-) registration of medicinal products, except for radioactive drugs, diagnostic agents, simple or complex (galenical) drugs made from crude drugs – in the amount equivalent to 100 EUR for each drug form, 10 EUR for each next dose, 10 EUR for each next drug package;
- For the state (re-)registration of radioactive medicinal products, diagnostic agents, simple or complex (galenical) medicinal products, active medicinal products with restricted use and such produced pursuant to formulations approved by the MHC of Ukraine (information of composition, manufacture (preparation) technology, quality control and medicinal product application), preparation made from donor blood or plasma – in the amount equivalent to 25 EUR for one name, 5 EUR for each next dose, 5 EUR for each next drug package. Additionally, the applicant pays a fee for expert examination under a contract on expert examination concluded between the Centre and the applicant. The fee amount depends on application type and is the same for all business entities (residents and non-residents).
This procedure shall be applied to active substances (active pharmaceutical ingredients), officinal dugs (except for medical immunobiological drugs) as well as preparations registered upon definition of the MHC of Ukraine as medicinal products, in particular: curative cosmetics, disinfectors and diagnostic agents.
Expert examination of the medicinal product registration file submitted for the state (re-) registration has following stages:
- Initial expert examination of the application in order to determine that the medicinal product does not belong to drugs prohibited for use in Ukraine and can be (re-) registered and that the application type has been specified correctly.
- Preliminary expert examination the goal of which is to determine the origin of the medicinal product offered by the applicant, drug manufacturing process (full technological cycle or its packing in bulk or carrying out of a certain stage as well as the level of influence of the manufacturing on the medicinal product characteristics etc.), compliance of the submitted registration file, participation level in the drug manufacturing, accuracy of information sources identification or provision of bibliographical information as to qualities of the drug if the applicant is responsible for final stages of the drug production with proofs that its activity cannot influence the medicinal product characteristics as to its quality, safety and efficacy.
The specialized expert examination of the registration file and results of additional examinations (trials) of the medicinal product is conducted in order to reach a motivated conclusion on the efficacy, safety and quality of the drug.
Leave a Comment